Andrea Lobo,  —

The U.S. Food and Drug Administration (FDA) has approved Medtronic’s Asleep Deep Brain Stimulation (DBS) surgery for people with Parkinson’s disease or essential tremor. “This is a significant advancement in our surgical offering, providing another safe and effective option for patients considering DBS,” Amaza Reitmeier, a vice…

Merck‘s U.S. and Canada life sciences business, MilliporeSigma, signed a memorandum of understanding with Gene Therapy Research Institution (GTRI), a Japanese clinical-stage biotech company, to accelerate the development of a viral vector-based gene therapy for Parkinson’s disease. Under the terms of the non-binding agreement, which symbolizes the parties’…

Nearly one-quarter of deceased athletes with chronic traumatic encephalopathy (CTE), a neurodegenerative disease associated with repetitive head impacts, experienced Parkinson’s disease-like symptoms during their lives, according to a study researchers said is the largest to date exploring the links among contact sports, CTE, and parkinsonism. The researchers found that…

Brenig Therapeutics has raised $65 million to advance its lead candidate, LRRK inhibitor BT-267, into human clinical trials as a possible treatment for idiopathic (of unknown cause) and LRRK2-associated Parkinson’s disease. The funds will be used to test BT-267 in healthy volunteers in a first-in-human study, Brenig said.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $6 million grant to Lario Therapeutics to advance early studies into CaV2.3 calcium channel inhibitors as a potential disease-modifying therapy for Parkinson’s disease. Lario’s preclinical program is being developed in collaboration with the Oxford…

Scientists have discovered a link between a mutation in the CARS gene and late-onset neurological disorders with symptoms, such as movement disorder, similar to those seen in Parkinson’s disease patients. The mutation, known as CARS E795V, was identified as the cause of a neurological condition affecting nine people…

A model that uses artificial intelligence (AI) to analyze electroencephalography (EEG)-based patterns of brain activity showed a potential to accurately diagnose Parkinson’s disease at early stages, according to a recent study from Australia. EEG, a non-invasive way of studying the brain’s electrical activity, is used to detect patterns of…

Four endurance athletes, one of whom has Parkinson’s disease, have embarked on a 2,800-mile rowing journey across the Pacific Ocean this summer. The team’s goal is to raise $28 million for Parkinson’s research through The Michael J. Fox Foundation for Parkinson’s Research(MJFF). The “Team Human Powered Potential” aims…

Low levels in the cerebrospinal fluid (CSF) — the liquid surrounding the brain and spinal cord — of proteins associated with nerve cell function may help in the early diagnosis of people with progressive supranuclear palsy (PSP), a form of atypical parkinsonism, according…

AskBio’s investigational gene therapy AB-1005 has been granted fast-track designation for Parkinson’s disease by the U.S. Food and Drug Administration (FDA), and innovation passport designation by the regulatory agency in the U.K. These designations are meant to accelerate the development and review process of therapy candidates designed to…